1. A process for the preparation of Fenoprofen calcium (1) with purity greater
than 99.0% by HPLC, comprising:
a) reducing 1-(3-phenoxyphenyl) ethanone (6) with a suitable reducing agent to form 1-(3-phenoxyphenyl) ethanol (5);
b) chlorinating intermediate (5) using a suitable chlorinating agent to form 1-(1-chloroethyl)-3-phenoxybenzene (4);
c) converting intermediate (4) to 2-(3-phenoxyphenyl) propanenitrile (3);
d) converting intermediate (3) to sodium 2-(3-phenoxyphenyl) propanoate (2) in presence of a suitable base; and
e) converting sodium 2-(3-phenoxyphenyl) propanoate (2) to Fenoprofen calcium (1).

2. The process according to claim 1, wherein the suitable reducing used in step a) is selected from a group comprising of lithium aluminum hydride (LiAlH4), sodium borohydride (NaBH4), sodium cyanoborohydride (NaBH3CN), sodium triacetoxyborohydride (NaBH (CH₃COO)₃), sodium borohydride (NaBH4), lithium cyanoborohydride, tetrabutylammonium cyanoborohydride ((CH3CH2CH2CH2)4N(BH3CN)), tetramethylammonium triacetoxyborohydride (NMe4BH(OAc)3.
3. The process according to claim 1, wherein the suitable chlorinating agent used in step b) is ammonium chloride.
4. The process according to claim 1, wherein the suitable base used in step d) used is selected from a group comprising of sodium hydroxide, potassium hydroxide, lithium hydroxide ,sodium carbonate, potassium carbonate, lithium carbonate, sodium bicarbonate, potassium bicarbonate, lithium bicarbonate, sodium methoxide, sodium ethoxide, sodium tert-butoxide, potassium methoxide, potassium ethoxide, potassium tert-butoxide, or mixtures thereof .
5. The process according to claim 1, wherein the suitable solvent used in the present invention is protic or aprotic solvents or its mixture selected from

the group comprising of methanol, ethanol, propanol, isopropanol, butanol, water, acetone, acetonitrile, benzene, dichloromethane, ethyl acetate, acetone, dichloromethane dimethylformamide, dimethyl sulfoxide, toulene, tetrahydrofuran or mixtures thereof.
6. A process for the preparation of Fenoprofen calcium (1) with purity
1. reducing 1-(3-phenoxyphenyl) ethanone (6) with a suitable reducing agent to form 1-(3-phenoxyphenyl) ethanol (5);
2. brominating intermediate (5) using a suitable chlorinating agent to form 1-(1-bromoethyl)-3-phenoxybenzene (9);
3. converting intermediate (9) to 2-(3-phenoxyphenyl) propanenitrile (3);
4. converting intermediate (3) to sodium 2-(3-phenoxyphenyl) propanoate (2) in presence of a suitable base; and
5. converting sodium 2-(3-phenoxyphenyl) propanoate (2) to Fenoprofen calcium (1).

7. The process according to claim 6, wherein the intermediate 1-(3-phenoxyphenyl) ethanone (6) used is prepared by heating 3-hydroxy acetophenone (8) with bromobenzene (7) in presence of potassium carbonate and metal catalyst, copper bronze.
8. The process according to claim 1, wherein the Fenoprofen calcium (1) obtained is having purity greater than 99.0% and total impurities less than 1% (w/w).
9. The process according to claim 1, wherein the Fenoprofen calcium (1) obtained is having characteristic X-Ray powder diffraction as shown in